Home
Registration
Schedule of Events
Venue Information
Important Information
Contact Us
 
 
F-Hotel

Fontainebleau Miami Beach Hotel
4441 Collins Ave 
Miami Beach, Florida 
33140 USA

 

ACHD QuERI / ES QuERI Program Combined Investigators' Meeting
October 19 - 21, 2018

Thank you for confirming your availability to attend the Adult Congenital Heart Disease (ACHD) QuERI and Eisenmenger Syndrome (ES) QuERI program combined Investigators' Meeting which will be hosted at the Fontainebleau Miami Beach Hotel in Miami Beach, Florida.

Please complete the Registration Form no later than Wednesday, September 12, 2018 so that we can ensure that all your travel and accommodation needs are met. Any registrations received after this date will be subject to hotel availability.

Should you have any questions or require any further information, please do not hesitate to contact us. Thank you in advance on behalf of the Steering Committee and our team and we very much look forward to welcoming you to Miami beach in October.
Anatoly Langer, MD
Chair, Canadian Heart Research Centre
Professor of Medicine
University of Toronto
 

 

ACHD QuERI / ES QuERI Program Combined Investigators' Meeting

7:45 AM

Registration and Breakfast

 
8:45 AM Welcome Michael J. Landzberg, MD
Gary Palmer, MD
8:55 Update on ACHD QuERI Anatoly Langer, MD
9:15 ECG in ACHD QuERI: Update from the core lab Gary Webb, MD
9:25 Echo in Early Detection of PAH: Results from the Core Lab Paul Forfia, MD
9:35 Five Critical Take-Aways From the New ACC/AHA ACHD Care Guidelines Curt J. Daniels, MD
10:00 Panel Discussion All Participants
10:15 Break  
10:35 Highlight’s from the 6th World Symposium    Vallerie V. McLaughlin, MD
11:00 Palliative Care in ACHD: Really Michael J. Landzberg, MD
11:25 Risk Stratification and Biomarker Sub-Study Update Alexander Opotowsky, MD
11:45 Panel Discussion and Q & A All Participants
12:10 PM Lunch  
1:00 Update on Eisenmenger QuERI Anatoly Langer, MD
1:20 The Emerging Role for Biomarkers to Better Understand and Care for Adults with Congenital Heart Disease Alexander Opotowsky, MD
1:40 Appropriate use of Echocardiography in PAH Managment Paul Forfia, MD
2:00 Next Steps for ACHD and ES QuERI Anatoly Langer, MD
2:10 Panel Discussion and Q & A All Participants
3:00 Close  

 

 

 


 

Project Leader ACHD & ES
Caroline Spindler
Canadian Heart Research Centre
Tel: 1-800-659-3734 x 224
spindlerc@chrc.net


Steering Committee

Michael J. Landzberg, MD (Chair ACHD)(Co-Chair ES)

Assistant Professor of Medicine
Harvard Medical School
Director, Boston Adult Congenital Heart (BACH) and Pulmonary Hypertension Program

Curt J. Daniels, MD (ACHD)
Director, Columbus Ohio Adult Congenital Heart Disease and Pulmonary Hypertension Programs
Associate Professor of Clinical Internal Medicine and Pediatrics
The Ohio State University
Nationwide Children’s Hospital

Paul Forfia, MD (ACHD)
Associate Professor of Medicine
Director, Pulmonary Hypertension/ Right Heart Failure and Pulmonary Thromboendarterectomy Program
Temple University Hospital

Anatoly Langer, MD
Chair, Canadian Heart Research Centre
Professor of Medicine, University of Toronto
Division of Cardiology, St. Michael’s Hospital

Vallerie V. McLaughlin, MD (ACHD) (Co-Chair ES)
Professor of Medicine
Division of Cardiovascular Medicine
Director, Pulmonary Hypertension Program
University of Michigan Health System

Gary Webb, MD (ACHD)
Director, The Cincinnati Adolescent and Adult Congenital Heart Disease Program
Cincinnati Children's Hospital Heart Institute

Gary Palmer, MD (non-voting)  
Senior VP Medical
Actelion Pharmaceuticals US